Gene Therapy Research in the Age of COVID-19: Study Startup Success for Infectious Disease, Oncology, and Rare Disease Research
Join colleagues from the research community on June 3 for an update and discussion of hot topics and emerging issues in infectious disease gene therapy research.
Gene therapy research is expanding rapidly in the clinical setting, especially in oncology, rare diseases, and infectious diseases—in fact, gene therapy research plays a crucial role in responding to the current coronavirus pandemic. The recent outbreak of the novel 2019 coronavirus (2019-nCov or SARS-CoV-2) has led to a surge of interest in coronavirus research. Researchers are working fast to develop medical countermeasures like genetically engineered vaccines. Key study startup obstacles must be addressed within the gene therapy field to keep research moving forward.
In this virtual panel discussion, representatives from industry and academia will explore the unique challenges gene therapy research poses for research sites, sponsors, CROs, and study participants.
Registration for this virtual event is free–act now to block your calendar and don’t miss this timely, engaging symposium.
- Optimizing study startup and overcoming obstacles
- How gene therapy research addresses infectious diseases like coronavirus
- Impact of manufacturing challenges on study startup
Who Should Attend:
Research professionals involved in designing and implementing clinical trials involving gene therapy, including representatives from sponsor, CRO, institutions, and site organizations.
Cost to Attend:
Attendance at this session has been approved for 1.00 contact hour of research specific continuing education on applications for Maintenance of ACRP’s CCRC®, CCRA®, CPI®, or ACRP-CP® certification designations. The Society of Clinical Research Associates (SOCRA – www.SOCRA.org) accepts documentation of candidate participation in continuing education programs for recertification if the program is applicable to clinical research regulations, operations or management, or to the candidate’s clinical research therapeutic area. This program offers 1 hour of CE credit. If you would like to obtain CE credits for a different credential, please check with your professional organization to determine if our event meets their continuing education requirements.
Certificate of Attendance:
After watching this symposium in its entirety and completing the symposium survey, you will receive a certificate of attendance. This certificate will be emailed to you within one business day of attending the symposium. Please note that if your organization has other staff members who wish to get a certificate of attendance, each person must register, watch the session in its entirety, and complete the survey.
PhD, RBP, SM(NRCM), CBSP
Director, Biosafety Services
Senior Clinical Scientist
J. Kaitlin Morrison
Clinical Development Manager
UNC Lineberger Comprehensive Cancer Center
Chief Manufacturing Officer